Sermorelin and tesamorelin
The clinic lists both compounds in its growth-hormone and metabolic optimization menu.
Provider source ↗
Unclaimed8 services cataloged
88MED
Omaha, NE · In-person care
Provider overview
About 88MED
88MED identifies Darin E. Jackson, MD, as its medical director and publishes physician-guided peptide, hormone, and weight-management care in Omaha. Its peptide page names sermorelin, tesamorelin, pentadeca arginate, gonadorelin, HCG, semaglutide, tirzepatide, and NAD+ injections. The profile records the provider's current menu while excluding promotional outcome claims and not independently verifying pharmacy, formulation, approval status, or individual suitability.
At a glance
- Market role
- Direct patient-care provider
- Care model
- In person
- Coverage
- 1 listed jurisdictions
- Pharmacy pathway
- Not publicly established
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Programs and services
Provider-advertised services, grouped for quick scanning with all details visible.
01
2Provider-advertised compounds
Pentadeca arginate
Pentadeca arginate appears in the clinic's recovery-oriented peptide catalog; availability and status require direct confirmation.
Provider source ↗02
3Hormone health
Gonadorelin and HCG
These hormone-support offerings are named in the peptide service catalog without an editorial claim about outcomes.
Provider source ↗Testosterone replacement therapy
The clinic publishes physician-guided testosterone evaluation and individualized treatment for men.
Provider source ↗Bioidentical hormone care for women
Women's bioidentical hormone replacement is listed among the practice's core programs.
Provider source ↗03
1Metabolic health
Semaglutide and tirzepatide
Both medications are published within physician-supervised medical weight-management services.
Provider source ↗04
1Longevity services
NAD+ injections
NAD+ injections are included in the clinic's cellular-energy and longevity-oriented service group.
Provider source ↗05
1Laboratory services
Clinical assessment and follow-up monitoring
The provider describes ongoing monitoring and response-based adjustment as part of peptide care.
Provider source ↗Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.
Coverage and research
Explore this provider’s markets
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Related provider profiles
Evidence
Sources reviewed
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
- 188MED — Official Website ↗
Supports: identity location and service scope · Checked Aug 2, 2026
- 288MED — Team ↗
Supports: medical director and team · Checked Aug 2, 2026
- 388MED — Peptide Therapy ↗
Supports: specific peptides and monitoring · Checked Aug 2, 2026
- 488MED — Hormone Replacement Therapy ↗
Supports: hormone services · Checked Aug 2, 2026